Panel Discussion and Q&A

EHA Library, Faculty / Presenters, 312347

Are we ready to treat high-risk patients with DLBCL differently? Relapsed/refractory disease – a continued area of unmet me

EHA Library, H Tilly, 312355

How molecular insights are changing the way we understand individual patients

EHA Library, Stefano Pileri, 312354

Interactive session: Welcome and voting on patient cases

EHA Library, Georg Hess, 312353

Can novel approaches for early response assessment guide timely clinical decisions?

EHA Library, A Schuh, 312352

Part II: Case studies, panel discussion and Q&A - From science to practice – a step closer to personalised care in NHL? - F

EHA Library, Faculty / Presenters, 312351

Are we ready to treat high-risk patients with DLBCL differently? Personalising front-line therapy – when standard treatment

EHA Library, Ulrich Jäger, 312350

Session Opening & Current landscape in the management of multiple myeloma

EHA Library, Mohamad Mohty, 312349

Future horizons for CAR T-cells, bispecifics and other advanced therapy medicinal products in multiple myeloma

EHA Library, Hermann Einsele, 312348

Follicular lymphoma from genetics to the clinic

EHA Library, Gilles Salles, 313417

What impact will CD20/CD3 bispecific antibodies have on the evolving NHL treatment landscape?

EHA Library, Franck Morschhauser, 312344

Session Opening & Zooming in on T-cell engaging therapies in NHL

EHA Library, S Dietrich, 312345

Understanding the latest clinical data for bispecific antibodies and other T-cell engaging therapies in NHL

EHA Library, Sarit Assouline, 312343

Focus on bispecific antibody safety: are there any new signals?

EHA Library, Martin Hutchings, 312342

Panel Discussion & Closing

EHA Library, Faculty / Presenters, 312341

Recommendations and consensus for the use of IgG therapy in patients with hematological malignancies and secondary immune d

EHA Library, M Albert, 312340

Future perspectives and closing remarks

EHA Library, Tadeusz Robak, 312339

Session Opening & The burden of infection in Chronic Lymphocytic Leukemia and Multiple Myeloma/COVID-19 in patients with ch

EHA Library, Tadeusz Robak, 312338

Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy

EHA Library, Marion Subklewe, 312337

Summary and close

EHA Library, Ifeyinwa Osunkwo, 312336

Impact and treatment of SCD: Hearing the patient viewpoint

EHA Library, John James, 312335

Living with SCD: Understanding the consequences

EHA Library, R Colombatti, 312334

Effective management of VOCs: Overcoming barriers and finding solutions

EHA Library, Ifeyinwa Osunkwo, 312333

Welcome and Introduction

EHA Library, Ifeyinwa Osunkwo, 312332

COVID-19 and SCD: The experts in conversation

EHA Library, Ifeyinwa Osunkwo, 312331

Toxicities in adult versus pediatric ALL patients and consequences for management

EHA Library, K Schmiegelow, 312330

Efficacy, tolerability and management strategies in the GMALL trials

EHA Library, Nicola GÖKBUGET, 312329

Asparaginase pharmacokinetics and pharmacodynamics

EHA Library, M Relling, 312328

Q&A

EHA Library, Faculty / Presenters, 312327

Questions and Discussion

EHA Library, Nicola GÖKBUGET, 312326

Q&A

EHA Library, Faculty / Presenters, 312325

Sickle cell disease as a chronic problem

EHA Library, Marianne de Montalambert, 313485

Iron overload, monitoring and management

EHA Library, Ali Taher, 313425

The molecular basis of p53 mutations in MDS

EHA Library, Benjamin Ebert, 313483

Niche contributions to bone marrow failure and clonal evolution in MDS

EHA Library, Marc Raaijmakers, 313482

Update on oral contraception and VTE

EHA Library, Marc Blondon, 313480

Potentially druggable targets in transformed disease

EHA Library, Davide Rossi, 313478

Current treatment options for transformed disease

EHA Library, Silvia Montoto, 313477

Biological basis of transformation

EHA Library, Ulf Klein, 313476

TTP vs HUS - Novel insights

EHA Library, Marie Scully, 313475

Immune thrombocytopenia (ITP): New insights on pathophysiology

EHA Library, John Semple, 313474

Inherited platelet disorders and mutations in hematopoietic transcription factors

EHA Library, A. Koneti Rao, 313473

Treatment of the older patient with AML

EHA Library, Courtney DiNardo, 313469

Eosinophilia

EHA Library, Andreas Reiter, 313466

Classification and clinical approach to atypical microcytic anemias

EHA Library, Patricia Aguilar Martinez, 313462

Basis of iron regulation for erythropoiesis

EHA Library, Laura SILVESTRI, 313461

Natural Killer Cell-Mediated Immunosurveillance of leukemia

EHA Library, Yenan Bryceson, 313459

Immunotherapy and other novel immunological therapies

EHA Library, Daniel Olive, 313458

Management of MM patients with high-risk disease

EHA Library, Jesús San Miguel, 313457

Testicular lymphoma

EHA Library, Annalisa Chiappella, 313453

Primary mediastinal lymphoma

EHA Library, Maurizio Martelli, 313452

New drugs and BMT: How to choose

EHA Library, Maria Domenica Cappellini, 313450

Genetic heterogeneity of congenital neutropenias

EHA Library, Karl Welte, 313444

Building blocks to optimize CLL treatment

EHA Library, Thorsten Zenz, 313440

Vulnerabilities of indolent lymphomas: The tumor and the microenvironment

EHA Library, Leticia Quintanilla de Fend, 313437

Management of post allogeneic HCT auto/alloimmune cytopenia

EHA Library, Andreas Holbro, 313436

Drug induced immune hemolytic disease: Diagnostic challenges

EHA Library, Quentin A Hill, 313435

New insights in the pathogenesis of autoimmune hemolytic diseases

EHA Library, Wilma Barcellini, 313434

Novel agents for phase 3 trials

EHA Library, Michel Zwaan, 313433

Advances in risk stratification in pediatric acute lymphoblastic leukemia

EHA Library, Anthony Moorman, 313432

ALL subtypes

EHA Library, Ilaria Iacobucci, 313431

Red cell transfusions: Current best practice and how to further optimize?

EHA Library, Marlijn Hoeks, 313430

Hydroxyurea: Fertility a still open question in adulthood

EHA Library, David Rees, 313421

Improving efficacy and persistence of CAR-T cell

EHA Library, Christian Chabannon, 313422

T-cell engaging antibodies for hematological diseases from approved therapies to new indications

EHA Library, Hermann Einsele, 313423

CAR T cells

EHA Library, Paula Rodríguez-Otero, 313424

Epidemiology of Hbpathies in Europe

EHA Library, Fred Piel, 313429

Novel treatment options

EHA Library, Subarna Chakravorty, 313426

Real life CAR T treatment

EHA Library, Catherine Thieblemont, 313427

A SINGLE NUCLEOTIDE POLYMORPHISM OF THE TRANSCRIPTION FACTOR GROWTH FACTOR INDEPENDENCE 1 (GFI1) ACCELERATES AML EVOLUTION AND SENSITIZES AML CELLS TO TREATMENT WITH DNA REPAIR INHIBITORS

EHA Library, Daria Frank, 294946

GENE THERAPY FOR FANCONI ANEMIA: A REPORT ON OUTCOMES IN NINE PATIENTS

EHA Library, Shameel Shafqat, 293987

THE PROGNOSTIC IMPACT OF CYTOGENETIC SCORES IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME TREATED WITH VENETOCLAX AND AZACITIDINE IN A PHASE 1 STUDY

EHA Library, Joshua Richter, 294712

AN INTACT GUT MICROBIOME PROTECTS GENETICALLY PREDISPOSED MICE AGAINST LEUKEMIA

EHA Library, Carolina Vicente-Dueñas, 294920

POSITRON EMISSION TOMOGRAPHY GUIDED OMISSION OF RADIOTHERAPY IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA: FINAL RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE III HD17 TRIAL BY THE GHSG

EHA Library, Peter Borchmann, 294921

TBI OR CHEMOTHERAPY BASED CONDITIONING FOR CHILDREN AND ADOLESCENTS WITH ALL: A PROSPECTIVE RANDOMIZED MULTICENTER-STUDY 'FORUM' ON BEHALF OF THE AIEOP-BFM-ALL-SG, IBFM-SG, INTREALL-SG AND EBMT-PD-WP

EHA Library, C Peters, 294922

NETRIN-1 REGULATES HEMATOPOIETIC STEM CELL DORMANCY AND FUNCTION VIA ITS RECEPTOR NEOGENIN WITH IMPLICATIONS FOR STEM CELL AGEING

EHA Library, Simon Renders, 294923

A NOVEL ROLE FOR IRON REGULATORY PROTEINS IN HEMATOPOIESIS

EHA Library, Bruno Galy, 294924

INDUCIBLE PHASE SEPARATION OF GSK3A MEDIATES ASPARAGINASE RESISTANCE IN ACUTE LEUKEMIAS

EHA Library, Laura Hinze, 294925

MEF2C DRIVES A MIXED PHENOTYPE ETP-ALL BY ACTIVATING B CELL GENES IN AN EARLY T CELL CONTEXT

EHA Library, Kirsten Canté-Barrett, 294926

BETTING ON PRC2 ALTERATION IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Guillaume Andrieu, 294927

MLL-AF4 RECRUITS H3K79ME2 VIA PAF1 DURING LEUKAEMIC TRANSFORMATION IN A NOVEL MODEL OF HUMAN FETAL LIVER-DERIVED T(4;11) INFANT ALL

EHA Library, Siobhan Rice, 294928

CONCURRENT LOSS OF BCOR AND DNMT3A PROMOTES ACUTE ERYTHROID LEUKEMIA (AEL) IN MICE

EHA Library, Paolo Sportoletti, 294947

LONGITUDINAL MULTI-OMICS ANALYSIS OF 13 MATCHED SAMPLE PAIRS COLLECTED FROM PEDIATRIC T-CELL LEUKEMIA PATIENTS AT INITIAL DIAGNOSIS AND AT RELAPSE

EHA Library, Paulina Richter-Pechanska, 294929

RECURRENT PAX5 FUSIONS IN MLL-GERMLINE INFANT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Giovanni Cazzaniga, 294930

SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520

EHA Library, Matteo Marchesini, 294931

TOWARDS MOLECULAR STRATIFICATION OF PAEDIATRIC T-CELL LYMPHOBLASTIC LYMPHOMAS BASED ON MINIMAL DISSEMINATED DISEASE AND NOTCH1/FBXW7 MUTATIONAL STATUS: THE FRENCH EURO-LB02 EXPERIENCE

EHA Library, Amelie Trinquand, 294932

MULTICOLOR FLOW CYTOMETRY PANEL WITH CCD79A GATING TO DETECT MINIMAL RESIDUAL DISEASE IN PATIENTS WITH B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA POST ANTI-CD19 CAR-T THERAPY BRIDGING TO ALLO-HSCT

EHA Library, Hui Wang, 294933

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOLLOWING DASATINIB-BASED TWO-STEP INDUCTION FOR PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS OF THE JALSG PH+ALL213 STUDY

EHA Library, Isamu Sugiura, 294934

FIRST-IN-HUMAN, UNIVERSAL ANTI-CD7 CAR-T THERAPY FOR RELAPSED AND REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R T-ALL)

EHA Library, Xinxin Wang, 294935

VENETOCLAX AND NAVITOCLAX IN RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOBLASTIC LYMPHOMA

EHA Library, Elias Jabbour, 294936

IMPROVED OUTCOME FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) AND AN ABL-CLASS FUSION FOLLOWING TREATMENT WITH A TYROSINE KINASE INHIBITOR: PRELIMINARY DATA FROM UKALL2011

EHA Library, Anthony Moorman, 294937

TISAGENLECLEUCEL FOR PEDIATRIC/YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: PRELIMINARY REPORT OF B2001X FOCUSING ON PRIOR EXPOSURE TO BLINATUMOMAB AND INOTUZUMAB

EHA Library, Andre Baruchel, 294938

ALLCAR19: UPDATED DATA USING AUTO1, A NOVEL FAST-OFF RATE CD 19 CAR IN RELAPSED /REFRACTORY B-ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Claire Roddie, 294939

DISRUPTION OF SERINE METABOLISM IS A NOVEL THERAPEUTIC STRATEGY IN FMS-LIKE TYROSINE KINASE 3 (FLT3) MUTANT ACUTE MYELOID LEUKAEMIA

EHA Library, Stefan Bjelosevic, 294940

MIR-125B-MEDIATED TARGETING OF ARID3A PROMOTES THE PROGRESSION OF MYELOID LEUKEMIA

EHA Library, Oriol Alejo-Valle, 294941

HIF2ALPHA PARTAKES TO AML DIFFERENTIATION BLOCKADE, AND ITS INHIBITION DRIVES AML DIFFERENTIATION

EHA Library, Daniela Magliulo, 294942

THROMBOPOIETIN RECEPTOR ACTIVATION BY A DOWN SYNDROME MYELOID LEUKEMIA VARIANT OF THE COMMON BETA CHAIN OF THE IL3, IL5 AND GM-CSF SIGNALLING COMPLEXES

EHA Library, Leila Varghese, 294943

ATF3 REGULATES SERINE SYNTHESIS AND CATABOLISM TO SUPPORT AGGRESSIVE SUB-TYPES OF ACUTE MYELOID LEUKEMIA

EHA Library, Stephen Sykes, 294944

ELUCIDATION OF THE ONCOGENIC EVI1 SUPERENHANCER COMPLEX IN INV(3)/T(3;3) LEUKEMIA

EHA Library, Sandra Kiehlmeier, 294945

CD20-TCB IN RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMA: DURABLE COMPLETE RESPONSES AND MANAGEABLE SAFETY OBSERVED AT CLINICALLY RELEVANT DOSES IN PHASE I DOSE ESCALATION

EHA Library, Michael J Dickinson, 293690